These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1817966)

  • 1. [3H]5-carboxamidotryptamine labels multiple high affinity 5-HT1D-like sites in guinea pig brain.
    Mahle CD; Nowak HP; Mattson RJ; Hurt SD; Yocca FD
    Eur J Pharmacol; 1991 Dec; 205(3):323-4. PubMed ID: 1817966
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and characterization of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain.
    Castro ME; Romón T; Castillo MJ; del Olmo E; Pazos A; del Arco C
    J Neurochem; 1997 Nov; 69(5):2123-31. PubMed ID: 9349558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
    Hemedah M; Coupar IM; Mitchelson FJ
    Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites.
    Boulenguez P; Chauveau J; Segu L; Morel A; Delaage M; Lanoir J
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1360-5. PubMed ID: 1762084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of the 5-HT terminal autoreceptor in the guinea-pig brain cortex.
    Roberts C; Watson J; Burton M; Price GW; Jones BJ
    Br J Pharmacol; 1996 Jan; 117(2):384-8. PubMed ID: 8789395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-5-O-carboxymethyl-glycyl[125I]tyrosinamide labels the 5-HT1D beta receptor subtype in human cortex.
    Beer MS; Middlemiss DN
    Eur J Pharmacol; 1993 Sep; 242(2):195-8. PubMed ID: 8253115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cyclic AMP reduces 5-HT1D receptor-mediated inhibition of [3H]5-hydroxytryptamine release from guinea-pig cortical slices.
    Ormandy GC
    Eur J Pharmacol; 1993 Jan; 244(2):189-92. PubMed ID: 8381745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical and striatal variations in drug competition studies with putative 5-hydroxytryptamine1D binding sites.
    Peroutka SJ
    Brain Res; 1991 Jul; 553(2):206-10. PubMed ID: 1657281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra.
    Nowak HP; Mahle CD; Yocca FD
    Br J Pharmacol; 1993 Aug; 109(4):1206-11. PubMed ID: 8401931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding profile of the novel 5-HT1B/1D receptor antagonist, [3H]GR 125,743, in guinea-pig brain: a comparison with [3H]5-carboxamidotryptamine.
    Audinot V; Lochon S; Newman-Tancredi A; Lavielle G; Millan MJ
    Eur J Pharmacol; 1997 May; 327(2-3):247-56. PubMed ID: 9200567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolabeling of central serotonin 5-HT1D beta receptors in the rat, mouse, and guinea pig with a specific anti-peptide antiserum.
    Langlois X; Gérard C; Darmon M; Chauveau J; Hamon M; el Mestikawy S
    J Neurochem; 1995 Dec; 65(6):2671-81. PubMed ID: 7595565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain.
    Grossman CJ; Kilpatrick GJ; Bunce KT
    Br J Pharmacol; 1993 Jul; 109(3):618-24. PubMed ID: 8358562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-694,247: a potent 5-HT1D receptor agonist.
    Beer MS; Stanton JA; Bevan Y; Heald A; Reeve AJ; Street LJ; Matassa VG; Hargreaves RJ; Middlemiss DN
    Br J Pharmacol; 1993 Nov; 110(3):1196-200. PubMed ID: 8298808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea-pig and human brain membranes.
    Bruinvels AT; Lery H; Nozulak J; Palacios JM; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):243-8. PubMed ID: 1407009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative autoradiography of 5-HT1E binding sites in rodent brains: effect of lesion of serotonergic neurones.
    Barone P; Millet S; Moret C; Prudhomme N; Fillion G
    Eur J Pharmacol; 1993 Nov; 249(2):221-30. PubMed ID: 8287904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of the 5-HT1D receptor binding affinity of 5-hydroxytryptamine, 5-carboxyamidotryptamine and sumatriptan in the central nervous system of seven species.
    Beer MS; Stanton JA; Bevan Y; Chauhan NS; Middlemiss DN
    Eur J Pharmacol; 1992 Mar; 213(2):193-7. PubMed ID: 1325915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain.
    Barone P; Jordan D; Atger F; Kopp N; Fillion G
    Brain Res; 1994 Feb; 638(1-2):85-94. PubMed ID: 8199879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain.
    To ZP; Bonhaus DW; Eglen RM; Jakeman LB
    Br J Pharmacol; 1995 May; 115(1):107-16. PubMed ID: 7647964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.